<SEC-DOCUMENT>0001193125-25-275888.txt : 20251112
<SEC-HEADER>0001193125-25-275888.hdr.sgml : 20251112
<ACCEPTANCE-DATETIME>20251112071530
ACCESSION NUMBER:		0001193125-25-275888
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		12
CONFORMED PERIOD OF REPORT:	20251112
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20251112
DATE AS OF CHANGE:		20251112

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CalciMedica, Inc.
		CENTRAL INDEX KEY:			0001534133
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				452120079
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39538
		FILM NUMBER:		251468773

	BUSINESS ADDRESS:	
		STREET 1:		505 COAST BOULEVARD SOUTH
		STREET 2:		SUITE 307
		CITY:			LA JOLLA
		STATE:			CA
		ZIP:			92037
		BUSINESS PHONE:		858-952-5500

	MAIL ADDRESS:	
		STREET 1:		505 COAST BOULEVARD SOUTH
		STREET 2:		SUITE 307
		CITY:			LA JOLLA
		STATE:			CA
		ZIP:			92037

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CalciMedica, Inc. /DE/
		DATE OF NAME CHANGE:	20230322

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GRAYBUG VISION, INC.
		DATE OF NAME CHANGE:	20170717

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GRAYBUG, Inc.
		DATE OF NAME CHANGE:	20150303
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ck0001534133-20251112.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- DFIN New ActiveDisclosure (SM) Inline XBRL Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2025-11-11T19:58:53.3336+00:00 -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonNumeric="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16" xmlns:ck0001534133="http://www.calcimedica.com/20251112" xmlns:utr="http://www.xbrl.org/2009/utr">
 <head>
  <title>8-K</title>
  <meta http-equiv="Content-Type" content="text/html"/>
 </head>
 <body style="padding:8px;margin:auto!important;z-index:0;-webkit-text-size-adjust:100%;position:relative;">
  <div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric id="F_0fe438d5-d815-4235-bbcc-2899cc553d5d" name="dei:AmendmentFlag" contextRef="C_dad156a8-ea9f-4dad-b927-4953a81dc893" format="ixt:fixed-false">false</ix:nonNumeric><ix:nonNumeric id="F_de30911b-3b26-4825-88c5-e5c5cee43d2e" name="dei:EntityCentralIndexKey" contextRef="C_dad156a8-ea9f-4dad-b927-4953a81dc893">0001534133</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="ck0001534133-20251112.xsd"/></ix:references><ix:resources><xbrli:context id="C_dad156a8-ea9f-4dad-b927-4953a81dc893"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-11-12</xbrli:startDate><xbrli:endDate>2025-11-12</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>
  <div style="z-index:2;min-height:0.5in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="border-top:2.25pt double #000000;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:5.75pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">UNITED STATES<br/>SECURITIES AND EXCHANGE COMMISSION<br/></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">WASHINGTON, D.C. 20549</span></p><p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><h2 style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:18pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">FORM </span><span style="font-size:18pt;font-family:Times New Roman;"><ix:nonNumeric id="F_6f290679-a266-4766-aa18-c401336efd6a" contextRef="C_dad156a8-ea9f-4dad-b927-4953a81dc893" name="dei:DocumentType"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">8-K</span></ix:nonNumeric></span></h2><p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CURRENT REPORT</span></p><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:100%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.398%;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Date of Report (Date of earliest event reported): </span><span><ix:nonNumeric id="F_78b312ea-94d5-4c44-95d7-01d0747d287e" contextRef="C_dad156a8-ea9f-4dad-b927-4953a81dc893" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">November 12, 2025</span></ix:nonNumeric></span></p></td>
    </tr>
   </table><p style="margin-left:40%;font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:24pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e15b8fb4-9862-40df-8f50-6dce7229dea3" contextRef="C_dad156a8-ea9f-4dad-b927-4953a81dc893" name="dei:EntityRegistrantName"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:24pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CalciMedica, Inc.</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Exact name of Registrant as Specified in Its Charter)</span></p><p style="margin-left:40%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:20%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:20%;box-sizing:content-box;"/>
     <td style="width:18%;box-sizing:content-box;"/>
     <td style="width:41%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td colspan="3" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_6b234716-d73d-4c5c-a967-0135f750f42c" contextRef="C_dad156a8-ea9f-4dad-b927-4953a81dc893" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Delaware</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_b6ceabb5-a6b0-4e7d-9a75-c4b182227ee0" contextRef="C_dad156a8-ea9f-4dad-b927-4953a81dc893" name="dei:EntityFileNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">001-39538</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_7776bd48-298a-4c7a-8308-565181636d93" contextRef="C_dad156a8-ea9f-4dad-b927-4953a81dc893" name="dei:EntityTaxIdentificationNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">45-2120079</span></ix:nonNumeric></span></p></td>
    </tr>
    <tr style="height:7pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td colspan="3" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(State or Other Jurisdiction<br/>of Incorporation)</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Commission File Number)</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(IRS Employer<br/>Identification No.)</span></p></td>
    </tr>
    <tr style="white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td colspan="3" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_4e71f8f1-c38d-48ba-8c50-ecda8cc176fc" contextRef="C_dad156a8-ea9f-4dad-b927-4953a81dc893" name="dei:EntityAddressAddressLine1"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">505 Coast Boulevard South</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">, </span><span><ix:nonNumeric id="F_38d1ec10-2d3c-4294-af75-18a8679008d7" contextRef="C_dad156a8-ea9f-4dad-b927-4953a81dc893" name="dei:EntityAddressAddressLine2"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Suite 307</span></ix:nonNumeric></span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td colspan="3" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_98971ee8-4798-4c20-abbe-9beaac4a8740" contextRef="C_dad156a8-ea9f-4dad-b927-4953a81dc893" name="dei:EntityAddressCityOrTown"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">La Jolla</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">, </span><span><ix:nonNumeric id="F_dd217415-a9dc-46af-9610-a3841058a8a5" contextRef="C_dad156a8-ea9f-4dad-b927-4953a81dc893" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">California</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_e518162e-56b1-435c-8292-95f5b5c23eb3" contextRef="C_dad156a8-ea9f-4dad-b927-4953a81dc893" name="dei:EntityAddressPostalZipCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">92037</span></ix:nonNumeric></span></p></td>
    </tr>
    <tr style="height:7pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td colspan="3" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Address of Principal Executive Offices)</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Zip Code)</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:100%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.125in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.398%;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Registrant&#8217;s Telephone Number, Including Area Code:</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span><span><ix:nonNumeric id="F_434da006-8b79-4439-9a86-287e50d02af8" contextRef="C_dad156a8-ea9f-4dad-b927-4953a81dc893" name="dei:CityAreaCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(858)</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span><span><ix:nonNumeric id="F_e9abc89c-93d1-4f41-8dd4-bb3179116e8d" contextRef="C_dad156a8-ea9f-4dad-b927-4953a81dc893" name="dei:LocalPhoneNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">952-5500</span></ix:nonNumeric></span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:100%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.125in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_b673a781-200e-4e3a-b8c2-1069cb8d2bae" contextRef="C_dad156a8-ea9f-4dad-b927-4953a81dc893" name="dei:EntityInformationFormerLegalOrRegisteredName"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Not Applicable</span></ix:nonNumeric></span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Former Name or Former Address, if Changed Since Last Report)</span></p><p style="margin-left:40%;font-size:10pt;margin-top:9.35pt;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:9.35pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:5%;box-sizing:content-box;"/>
     <td style="width:95%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_894568ec-1375-4be7-96a9-6f9584010090" contextRef="C_dad156a8-ea9f-4dad-b927-4953a81dc893" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_8f2a4934-cf62-47ef-b2bb-07701f3eeccf" contextRef="C_dad156a8-ea9f-4dad-b927-4953a81dc893" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_412d8a88-34f2-4e2b-b945-7b9bad9644fa" contextRef="C_dad156a8-ea9f-4dad-b927-4953a81dc893" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_88c10cef-b8a0-495b-bdb2-1dc2b7af5118" contextRef="C_dad156a8-ea9f-4dad-b927-4953a81dc893" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:9pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Securities registered pursuant to Section 12(b) of the Act:</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:38%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:15%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:45%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><br/>Title of each class</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Trading<br/>Symbol(s)</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><br/>Name of each exchange on which registered</span></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_b06a85f0-bd12-41cd-90af-b15f9296ddad" contextRef="C_dad156a8-ea9f-4dad-b927-4953a81dc893" name="dei:Security12bTitle"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Common Stock, par value $0.0001 per share</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_56bd88d1-e8d5-4e68-9ca3-06d914723d71" contextRef="C_dad156a8-ea9f-4dad-b927-4953a81dc893" name="dei:TradingSymbol"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">CALC</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_a5aed3c8-74e0-4069-aae8-e0e5ffa35fea" contextRef="C_dad156a8-ea9f-4dad-b927-4953a81dc893" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">The Nasdaq</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Capital Market</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#8239;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;&#8239;240.12b-2 of this chapter).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Emerging growth company </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_2a0162da-4bb7-40df-9b6f-e6eb6630319d" contextRef="C_dad156a8-ea9f-4dad-b927-4953a81dc893" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#9746;</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_4a2eaf91-70ec-477b-aebc-ce1bb4a88417" contextRef="C_dad156a8-ea9f-4dad-b927-4953a81dc893" name="dei:EntityExTransitionPeriod" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="z-index:2;min-height:0.5in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 2.02.             Results of Operations and Financial Condition.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On November 12, 2025 CalciMedica, Inc. issued a press release announcing its financial results for the fiscal quarter ended September 30, 2025. A copy of the press release is attached as Exhibit 99.1 to this report.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The information in this Item 2.02, including Exhibit 99.1 to this report, shall not be deemed to be &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;). The information contained in this Item 2.02 and in the accompanying Exhibit 99.1 shall not be incorporated by reference into any other filing under the Exchange Act or under the Securities Act, except as shall be expressly set forth by specific reference in such filing.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 9.01.            Financial Statements and Exhibits.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">(d) Exhibits</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:7.14%;box-sizing:content-box;"/>
     <td style="width:4.08%;box-sizing:content-box;"/>
     <td style="width:88.78%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Exhibit</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Number</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Description</span></p></td>
    </tr>
    <tr style="height:5.75pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">99.1</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="ck0001534133-ex99_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Press Release dated November 12, 2025</span></a></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">104</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="z-index:2;min-height:0.5in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:9.35pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SIGNATURES</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:9.35pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:6%;box-sizing:content-box;"/>
     <td style="width:44%;box-sizing:content-box;"/>
     <td style="width:9%;box-sizing:content-box;"/>
     <td style="width:41%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:4.3pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">CalciMedica, Inc.</span></p></td>
    </tr>
    <tr style="white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date:</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">November 12, 2025</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid;padding-right:0in;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">/s/ A. Rachel Leheny, Ph. D.</span></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Name:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Title:</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0.7pt;font-family:Times New Roman;margin-bottom:9.35pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">A. Rachel Leheny, Ph. D.<br/>Chief Executive Officer<br/></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
 </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ck0001534133-ex99_1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!-- DFIN ActiveDisclosure (SM) HTML Document - http://www.dfinsolutions.com/ --><!-- Creation Date :2025-11-11T19:58:53.4662+00:00 --><!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html>
 <head>
  <title>EX-99.1</title>
 </head>
 <body style="padding:8px;margin:auto!important;z-index:0;-webkit-text-size-adjust:100%;position:relative;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:66.667%;text-indent:20%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Exhibit 99.1	</font></p><p style="margin-left:13.333%;text-indent:7.692%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img205673473_0.jpg" alt="img205673473_0.jpg" style="width:303px;height:59px;"></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">CalciMedica Reports Third Quarter 2025 Financial Results and Provides Clinical &amp; Corporate Updates</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Segoe UI',sans-serif;font-style:italic;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Segoe UI',sans-serif;font-style:italic;font-kerning:none;min-width:fit-content;">Enrollment ongoing in Phase 2 KOURAGE trial of Auxora&#153; in acute kidney injury (AKI) with respiratory failure; data expected in 1H 2026</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Segoe UI',sans-serif;font-style:italic;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-style:italic;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-style:italic;font-kerning:none;min-width:fit-content;">Positive discussions with FDA on pivotal trial in acute pancreatitis (AP); final trial design expected in 1H 2026</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Segoe UI',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-style:italic;font-kerning:none;min-width:fit-content;">Cash position expected to fund operations into 2H 2026</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">LA JOLLA, Calif., November 12, 2025</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#x2013; CalciMedica Inc. (&#x201c;CalciMedica&#x201d; or the &#x201c;Company&#x201d;) (Nasdaq: CALC), a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for acute and chronic inflammatory and immunologic illnesses, today reported financial results for the third quarter ended September 30, 2025 and provided clinical and corporate updates.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#x201c;Enrollment continues in our Phase 2 KOURAGE trial evaluating Auxora in patients with AKI with respiratory failure, and we look forward to sharing data in the first half of 2026. As we approach this milestone, we are encouraged by AKI animal model data recently shared at ASN and results in PAH animal models published in </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-style:italic;font-kerning:none;min-width:fit-content;">JCI Insight,</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> both of which provide further mechanistic rationale for CRAC channel inhibition as a promising approach for treating AKI,&#x201d; said Rachel Leheny, Ph.D., CEO of CalciMedica. &#x201c;Additionally, discussions with the FDA have been positive regarding our program in AP. We expect our recently announced collaboration with Telperian and its AI-driven analytics platform will enable us to leverage insights from completed Auxora trials to optimize the design of our pivotal trial in AP, which we expect to finalize in the first half of 2026.&#x201d;</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Recent Clinical &amp; Corporate Highlights:</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:'Calibri',sans-serif;font-style:italic;font-kerning:none;min-width:fit-content;">Clinical Updates &amp; Anticipated Milestones</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-style:italic;font-kerning:none;min-width:fit-content;">Acute Kidney Injury (AKI) with Respiratory Failure Program Update</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Enrollment ongoing in Phase 2 KOURAGE trial: </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Enrollment is ongoing in KOURAGE, CalciMedica&#x2019;s randomized, double-blind, placebo-controlled Phase 2 trial of Auxora&#153; in patients with Stage 2 or Stage 3 AKI with respiratory failure. The Company plans to enroll 150 patients in KOURAGE, with data expected in the first half of 2026.</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Poster presentation at the American Society of Nephrology (ASN) Kidney Week 2025: </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">In November 2025, CalciMedica and collaborators from Indiana University School of Medicine, including David P. Basile, Ph.D., Professor of Anatomy, Cell Biology and Physiology, presented a </font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">1</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;visibility:hidden;word-break:keep-all;display:inline-flex;justify-content:flex-start;"></font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">poster titled &#34;</font><font style="color:#0563c1;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Store-Operated Calcium-Channel Inhibitor Auxora Improves Kidney Function Following Ischemia-Induced AKI in Rats</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#34; at ASN Kidney Week 2025. In the study, treatment with Auxora versus placebo significantly reduced Th17 cells in both the kidney and lung, significantly increased glomerular filtration rate (GFR), and decreased renal injury in a rat model of AKI. The findings, particularly the new observations of IL-17 reductions in the lung, provide strong mechanistic support for Auxora as a potential treatment for severe AKI with respiratory failure. The inclusion and exclusion criteria of CalciMedica's Phase 2 KOURAGE study are expected to enrich for patients with elevated IL-17 levels, which have been shown to correlate with mortality and major adverse kidney events in severe AKI.</font></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-style:italic;font-kerning:none;min-width:fit-content;">Acute Pancreatitis (AP) Program Update</font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-style:italic;font-kerning:none;min-width:fit-content;"> </font></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Positive discussions with the U.S. Food and Drug Administration (FDA) on pivotal trial in AP:</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> CalciMedica has had constructive engagement with the FDA regarding the design of a pivotal trial in AP. The Company expects to finalize the pivotal trial design in the first half of 2026. This study is anticipated to be the first pivotal trial in the U.S. for a therapeutic in AP.</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Announced collaboration with Telperian to leverage AI insights to support the design of pivotal trial design in AP: </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">In October 2025, CalciMedica and Telperian announced a collaboration to integrate Telperian&#x2019;s advanced AI platform into analyses of data from completed Auxora clinical trials.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Insights from this work are expected to help inform the finalization of the design of CalciMedica&#x2019;s pivotal trial in AP and support ongoing regulatory discussions with the FDA.</font></div></div><p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-style:italic;font-kerning:none;min-width:fit-content;">Preclinical Program Updates</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-style:italic;font-kerning:none;min-width:fit-content;"> </font></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Publication in </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-style:italic;font-kerning:none;min-width:fit-content;">JCI</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-style:italic;font-kerning:none;min-width:fit-content;">Insight</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">:</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> In November 2025, a manuscript authored by CalciMedica and collaborators titled &#34;</font><font style="color:#0563c1;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Combination of Orai1 Inhibitor CM5480 with Specific Therapy Mitigates Pulmonary Hypertension and Its Cardiac Dysfunction</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#34; was published in </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-style:italic;font-kerning:none;min-width:fit-content;">JCI Insight.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> The publication describes preclinical data supporting CalciMedica&#x2019;s proprietary CRAC channel inhibitor candidate, CM5480, as a potential first-in-class, differentiated therapy for the treatment of pulmonary arterial hypertension (PAH). In an animal model of PAH, CM5480 restored or improved multiple disease-affected pathways and functions&#x2014;including heart contraction and cardiac output, gene expression profiles, DNA repair, and metabolism. Treatment with CM5480 also significantly reduced right ventricular dysfunction (RVD) both as a monotherapy and in combination with existing PAH therapies. Beyond PAH, these findings suggest that CRAC channel inhibition may directly improve RVD, which occurs in approximately half of patients with sepsis, the leading cause of AKI. This potential effect provides additional mechanistic support for Auxora as a potential treatment for AKI with respiratory failure.</font></div></div><p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Financial Results for the Third Quarter Ended September 30, 2025:</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Cash Position: </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Cash, cash equivalents, and short-term investments were $14.1 million as of September 30, 2025. The Company expects its cash position to be sufficient to fund its current operating plan into the second half of 2026.</font></p><p style="margin-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">2</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="margin-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">R&amp;D Expenses: </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Research and development expenses were $3.9 million for the three months ended September 30, 2025, compared to $3.6 million for the three months ended September 30, 2024. The increase of $0.3 million was primarily due to an increase in clinical trial and preclinical activities offset by a decrease in consultants and other costs.</font></p><p style="margin-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">G&amp;A Expenses: </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">General and administrative expenses were $1.8 million for the three months ended September 30, 2025, compared to $2.2 million for the three months ended September 30, 2024. The decrease of $0.4 million was primarily due to a decrease in professional services and consultants and other costs.</font></p><p style="margin-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Other Income (Expense): </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Other expenses were $2.2 million for the three months ended September 30, 2025, compared to other income of $0.1 million for the three months ended September 30, 2024. The increase of $2.3 million in expenses was primarily due to a non-cash increase in fair value adjustments to the Company&#x2019;s financial instruments.</font></p><p style="margin-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Net Loss: </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Net loss was $7.8 million, or $0.52 per basic and diluted share, for the three months ended September 30, 2025, compared to $5.6 million, or $0.50 per basic and diluted share, for the three months ended September 30, 2024.<br><br></font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">  </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">About CalciMedica</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">CalciMedica is a clinical-stage biopharmaceutical company focused on developing novel CRAC channel inhibition therapies for inflammatory and immunologic diseases. CalciMedica's proprietary technology targets the inhibition of CRAC channels to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory and immunologic diseases for which there are currently no approved therapies. CalciMedica's lead product candidate Auxora&#153; has demonstrated positive and consistent clinical results in multiple completed efficacy clinical trials and been well-tolerated in over 350 critically ill patients dosed. CalciMedica has announced data for a Phase 2b trial (called CARPO &#x2013; </font><font style="color:#0563c1;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">NCT04681066</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">) in patients with acute pancreatitis (AP) and accompanying systemic inflammatory response syndrome (SIRS) and for a Phase 2 trial (called CARDEA &#x2013; </font><font style="color:#0563c1;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">NCT04345614</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">) in patients with COVID pneumonia. The Company is currently conducting a Phase 2 trial (called KOURAGE &#x2013; </font><font style="color:#0563c1;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">NCT06374797</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">) in patients with acute kidney injury (AKI) with associated respiratory failure, with data expected in the first half of 2026. For more information, please visit </font><font style="color:#0563c1;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">www.calcimedica.com</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Forward-Looking Statements</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">This communication contains forward-looking statements which include, but are not limited to CalciMedica's expected cash runway; CalciMedica's planned and ongoing clinical trials and the timing, design, expected patient enrollment thereof and the expected timing for updates and the release of data from its Phase 2 KOURAGE trial of Auxora in AKI with associated respiratory failure in the first half of 2026; the positive nature of discussions with the FDA concerning design of a pivotal trial in AP and expectation of a final trial design in first half of 2026; the potential benefits of CalciMedica's collaboration with Telperian, including with respect to the design of CalciMedica&#x2019;s pivotal trial in AP; CalciMedica&#x2019;s belief that Auxora reduces Th17 cells in both the kidney and lung, increases glomerular filtration rate, and decreases renal injury; the potential regarding preclinical animal studies of Auxora; the potential of CM5480 to provide therapeutic benefits in PAH; and the potential of CalciMedica's proprietary</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">3</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">technology to provide therapeutic benefits in acute and chronic inflammatory and immunologic diseases. These forward-looking statements are subject to the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. CalciMedica's expectations and beliefs regarding these matters may not materialize. Actual outcomes and results may differ materially from those contemplated by these forward-looking statements as a result of uncertainties, risks, and changes in circumstances, including but not limited to risks and uncertainties related to: the impact of fluctuations in global financial markets on CalciMedica's business and the actions it may take in response thereto; CalciMedica's ability to execute its plans and strategies; the ability to obtain and maintain regulatory approval for Auxora; results from clinical trials or preclinical studies may not be indicative of results that may be observed in the future; potential safety and other complications from Auxora; the scope, progress and expansion of developing and commercializing Auxora; the size and growth of the market therefor and the rate and degree of market acceptance thereof; economic, business, competitive, and/or regulatory factors affecting the business of CalciMedica generally; CalciMedica's ability to protect its intellectual property position; the impact of government laws and regulations; and CalciMedica's financial position and need for additional capital. Additional risks and uncertainties that could cause actual outcomes and results to differ materially from those contemplated by the forward-looking statements are included under the caption &#34;Risk Factors&#34; in CalciMedica's Quarterly Report on Form 10-Q for the quarter ended September 30, 2025, being filed with the Securities and Exchange Commission (SEC) later today, and elsewhere in CalciMedica's subsequent reports on Form 10-K, Form 10-Q or Form 8-K filed with the SEC from time to time and available at </font><font style="color:#0563c1;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">www.sec.gov</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">. These documents can be accessed on CalciMedica's web page at </font><font style="color:#0563c1;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">ir.calcimedica.com/financials-filings/sec-filings</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">. The forward-looking statements contained herein are made as of the date hereof, and CalciMedica undertakes no obligation to update them after this date, except as required by law.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Contact Information</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Kevin Murphy</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">calcimedica@argotpartners.com</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">(212) 600-1902</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">4</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">CALCIMEDICA, INC.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="condensed_balance_sheets"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Condensed Consolidated</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> Balance Sheets</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">(in thousands, except par value and share amounts)</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">(Unaudited)</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:66.967%;box-sizing:content-box;"></td>
     <td style="width:1.48%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
     <td style="width:13.037%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
     <td style="width:1.48%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
     <td style="width:13.037%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">September 30,<br>2025</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,<br>2024</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Assets</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Current assets</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash and cash equivalents</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,470</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,935</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Short-term investments</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,614</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,734</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid clinical trial expenses</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">230</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">748</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other prepaid expenses and current assets</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">539</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">248</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:3.707%;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total current assets</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14,853</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19,665</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Property and equipment, net</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">49</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">119</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other assets</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:3.707%;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total assets</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14,913</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19,794</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Liabilities and Stockholders&#x2019; Equity (Deficit)</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Current liabilities</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accounts payable</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,133</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,998</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued clinical trial costs</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,523</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">820</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued expenses</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,025</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">866</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:3.707%;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total current liabilities</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,681</font></p></td>
     <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,684</font></p></td>
     <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Long-term liabilities</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Promissory note</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,900</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Warrant liability</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,600</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,700</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:3.707%;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total liabilities</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,181</font></p></td>
     <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,384</font></p></td>
     <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Commitments and contingencies (Note 8)</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stockholders&#x2019; equity (deficit)</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Preferred stock, $0.0001 par value; 10,000,000 shares authorized at September 30, 2025 and December 31, 2024, respectively; no shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Common stock, $0.0001 par value; 500,000,000 shares authorized at September 30, 2025 and December 31, 2024, respectively; 14,257,234 and 13,481,917, issued and outstanding at September 30, 2025 and December 31, 2024, respectively</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Additional paid-in capital</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">178,293</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">174,166</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accumulated deficit</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(178,566</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">)</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(159,764</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">)</font></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accumulated other comprehensive income</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:3.707%;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total stockholders&#x2019; equity (deficit)</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(268</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">)</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14,410</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:3.707%;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total liabilities and stockholders&#x2019; equity</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14,913</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19,794</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">5</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">CALCIMEDICA, INC.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="condensed_statements_operations"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Condensed Consolidated Statemen</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">ts of Operations</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">(in thousands, except share and per share amounts)</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">(Unaudited)</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:50.34%;box-sizing:content-box;"></td>
     <td style="width:1.18%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
     <td style="width:9.236%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
     <td style="width:1.18%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
     <td style="width:9.236%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
     <td style="width:1.18%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
     <td style="width:9.236%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
     <td style="width:1.18%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
     <td style="width:9.236%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Three Months Ended September 30,</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Nine Months Ended September 30,</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating expenses:</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,851</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,546</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,127</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,647</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">General and administrative</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,767</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,190</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,609</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,385</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:3.707%;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total operating expenses</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,618</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,736</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18,736</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18,032</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Loss from operations</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(5,618</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">)</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(5,736</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">)</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(18,736</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">)</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(18,032</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">)</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other income (expense):</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in fair value of financial instruments</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(2,000</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">)</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(100</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">)</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">200</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,790</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Interest expense</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(326</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">)</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(1,097</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">)</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Interest income</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">140</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">218</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">562</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">800</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other income</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">269</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total other income (expense)</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(2,186</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">)</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">118</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(66</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">)</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,590</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(7,804</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">)</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(5,618</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">)</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(18,802</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">)</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(9,442</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">)</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss per share - basic and diluted</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(0.52</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">)</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(0.50</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">)</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(1.28</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">)</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(0.88</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">)</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average number of shares outstanding used in<br>&#160;&#160;&#160;computing net loss per share&#x2014;basic and diluted</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,076,456</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,134,964</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14,734,641</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,674,531</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">6</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>img205673473_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img205673473_0.jpg
M_]C_X  02D9)1@ ! @$ W #<  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" "' K8# 2(  A$! Q$!_\0
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MZ\(2=*FZ=*+A5Q%.K3Z<-0]LVY74(Z-IV;EH[+?O=^7J?9/[:O\ P6D_;/\
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MSR!\./'X.,],_P#"W#CCC.#ZXK^>$G))/4\FBO\ 2/ASP.\,^&LIPF4X7AC
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M3_X(-?#7Q1\-/ 7[3G[9VEZGXFN_'.DWVO>$?@!?1W^AZ+8>&M8M!;^&M?\
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MU*&!VN!:F^CGC0O.L6-\H/\ JI^"?A_X#^&NB_\ "-_#GP3X1\ >'?M<]_\
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M/*\+A:?LY4E.K7A3YL/5KXXET'RRI:2DKM17NV\U]F7DEZVT;_GK_P"#BO\
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MPSM'++H,%WI[6UL0][?6\LD4$GN/[?\ ^TE_PS9^S[X@US1K];3Q]XO+^#O
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M^\6ZA+H>HQ16QU*TU"UT6VL;/4Q;0)+IVK7D<T%OJ-I/:P^X_MF?\$Y?A?\
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M\.0_%7_1>_#_ /X1FH__ "XK]<_UH^E7_P!$1D/_ (!E/_T5_P!7?E;^</\
M4']GU_T=;B[_ ,#S_P O^K?_ -7?;3[A_P"'MW[('_06\=_^$E'_ /+>OP*_
M;L^,/@#X[_M'>,/B5\-?M9\+Z[9^&Q!)?:;%I5W+>6'AK1]-U&6XMHI9@9)+
MZSN&,SR-),"LCG+5^BG_  Y#\5?]%[\/_P#A&:C_ /+BC_AR'XJ_Z+WX?_\
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MX1\.W7G)/-::9IT-M=ZPQ@:#=937%S<6<,<L<^^6W2Y1E$<WS?E;_P %(?\
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M'AO5EC2WU?1-4MO+NK"_MC@H_E7$=M=Q7%M#^MG[(G_!PG^V3^S?H'A7X?\
MQ$T_PI^T5\.?#*0:?;Q>-FO]$^)-MX>L=*_L_3M"TWXBZ2UQ')%:3QVUU_:/
MBWPIXRU>6-);(WZ020&T_=O%OPCQG'6,P_&7!V+P>.Q&.P.&6)PL\73A0S"C
M1H1C@<;EN,DWAG*KAE3HSI5:E&A)4Z=:-;GG53ZL1AW5:JTVFVE=-Z25M'%[
M;=[+K<_T Z^#/^"B7[=OPS_8'_9Z\4?$WQ9K.DM\0]8TC7-)^"G@*Z62]O\
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M.:IX:TOR+>--.OO%^N:_)XAN!-'$MQ/)J#:'I8?[1+(L26D20K&-^_\ 0_\
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M@^9VQDFDT;Q/X:\1_:?^$>\0Z'KWV+R1>?V-JUAJGV0W'F_9Q<_8;B?R//\
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MC&<&X32FE*+<9)IM&2E*+O%N+[IM/[UJ?,'[-G[&'[+_ .R!8^);#]G#X/\
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MTZ=&>8YWF6,S7'SHT4XT:4L9CZV(Q$J=*+<:=-U'&";44D%>&_&7]FSX(_M
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
6**** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>ck0001534133-20251112.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2025-11-11T19:58:53.4018+00:00 -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema targetNamespace="http://www.calcimedica.com/20251112" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:ck0001534133="http://www.calcimedica.com/20251112" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" namespace="http://fasb.org/us-gaap/2025"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" namespace="http://xbrl.sec.gov/dei/2025"/>
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType roleURI="http://www.calcimedica.com/20251112/taxonomy/role/Role_DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>75000 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbase id="lnk">
        <link:roleRef roleURI="http://www.calcimedica.com/20251112/taxonomy/role/Role_DocumentDocumentAndEntityInformation" xlink:href="ck0001534133-20251112.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple"/>
        <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:title="labelLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInformationFormerLegalOrRegisteredName" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, State or Country Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Issuer Tender Offer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Tender Offer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title of 12(b) Security</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Information, Former Legal or Registered Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Ex Transition Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInformationFormerLegalOrRegisteredName" xlink:to="dei_EntityInformationFormerLegalOrRegisteredName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
        </link:labelLink>
        <link:presentationLink xlink:role="http://www.calcimedica.com/20251112/taxonomy/role/Role_DocumentDocumentAndEntityInformation" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInformationFormerLegalOrRegisteredName" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="49.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="50.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="51.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="52.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="53.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="54.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="55.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="56.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="57.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="58.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="59.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="60.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="61.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="62.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="63.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="64.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityInformationFormerLegalOrRegisteredName" order="65.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="66.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="67.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="68.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="69.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityExTransitionPeriod" order="70.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="71.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="72.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="73.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
      </link:linkbase>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>6
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th"><div>Nov. 12, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Nov. 12,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CalciMedica, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001534133<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39538<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">45-2120079<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">505 Coast Boulevard South<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 307<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">La Jolla<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92037<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(858)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">952-5500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationFormerLegalOrRegisteredName', window );">Entity Information, Former Legal or Registered Name</a></td>
<td class="text">Not Applicable<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CALC<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationFormerLegalOrRegisteredName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Former Legal or Registered Name of an entity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationFormerLegalOrRegisteredName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>25</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="ck0001534133-20251112.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>75000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.calcimedica.com/20251112/taxonomy/role/Role_DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="ck0001534133-20251112.htm">ck0001534133-20251112.htm</File>
    <File>ck0001534133-20251112.xsd</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="25">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>12
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ck0001534133-20251112.htm": {
   "nsprefix": "ck0001534133",
   "nsuri": "http://www.calcimedica.com/20251112",
   "dts": {
    "inline": {
     "local": [
      "ck0001534133-20251112.htm"
     ]
    },
    "schema": {
     "local": [
      "ck0001534133-20251112.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    }
   },
   "keyStandard": 25,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 26,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 25
   },
   "report": {
    "R1": {
     "role": "http://www.calcimedica.com/20251112/taxonomy/role/Role_DocumentDocumentAndEntityInformation",
     "longName": "75000 - Document - Document And Entity Information",
     "shortName": "Document And Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "C_dad156a8-ea9f-4dad-b927-4953a81dc893",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "h2",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20251112.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_dad156a8-ea9f-4dad-b927-4953a81dc893",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "h2",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20251112.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.calcimedica.com/20251112/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.calcimedica.com/20251112/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.calcimedica.com/20251112/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://www.calcimedica.com/20251112/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.calcimedica.com/20251112/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.calcimedica.com/20251112/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.calcimedica.com/20251112/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.calcimedica.com/20251112/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.calcimedica.com/20251112/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.calcimedica.com/20251112/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.calcimedica.com/20251112/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://www.calcimedica.com/20251112/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.calcimedica.com/20251112/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.calcimedica.com/20251112/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationFormerLegalOrRegisteredName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInformationFormerLegalOrRegisteredName",
     "presentation": [
      "http://www.calcimedica.com/20251112/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information, Former Legal or Registered Name",
        "documentation": "Former Legal or Registered Name of an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.calcimedica.com/20251112/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.calcimedica.com/20251112/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.calcimedica.com/20251112/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.calcimedica.com/20251112/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.calcimedica.com/20251112/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.calcimedica.com/20251112/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.calcimedica.com/20251112/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.calcimedica.com/20251112/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.calcimedica.com/20251112/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.calcimedica.com/20251112/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>13
<FILENAME>0001193125-25-275888-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-25-275888-xbrl.zip
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M#ZF%CS3P#9=:OFTR3Q?<\\T]4B[_ASW$EU88W8.@(8N1:#^J7X?-B6%.'[4
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MOF_W_LRU?'[U%C3!MX0&:K#58*O!5H-M/6"KG3WKLMO05-=#+]0I-SU!+2]
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M>%]%FL_#,.*0J6\;.NIQ-P/5=?1VB>CM83-(Q>#C#X?-3M&-/_X_4$L#!!0
M   ( .TY;%LJ-_P0:@D  &9N   9    8VLP,# Q-3,T,3,S+3(P,C4Q,3$R
M+GAS9.U=46_;-A!^WZ_@O)<6JRS+J=O&J#-D23L82YL@3K%APU#($NT0E4F/
MDA+GWX^D1$64*5FV(\F9"@2)(AV/WQV/)^K3T7[_RVKA@3M(?43PJ&-U>QT
ML4-<A.>CSI>)<3HY&X\[OYS\\/Y'PP#G'\>?P6=X#TZ= -W!<^0['O%#"L&+
MR:>7X,]?KR_ Q+F%"QN<$R=<0!P  ]P&P7)HFO?W]UUWAK!/O#!@W?E=ARQ,
M8!BQ\C,*;7X>G-L!!,-^KS\P+(O]W%C'P\&[X>"H^[IGO?NYUQOV>JEF9/E
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MJ!<@NN'I_K&CRI-G'I^UGW4?5N!189R-JK="I;OVL^!15^5#D";$=LU%8M7
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M)!*HU/@S_6JXD,=L</%1CR_;>FCV#7Y=NE>Q:3+TI1H;Q7.7 /Q$K>B_3\X
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M0E\^D3A/]6UD_)7&+U(^&X#2YLJIMED^9&K0SH(;!6:T?( TC9G:1Z =\=9
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M@E78D"OI,AYXS)-^$@O/ BBSA/@D?@N"021^[1*_M6J;I"\92X36A-:$UD5
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M+GAS9%!+ 0(4 Q0    ( .TY;%M+%:-B5"D  "N8 P 7              "
M 5D>  !C:S P,#$U,S0Q,S,M97@Y.5\Q+FAT;5!+!08      P # -,   #B
%1P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>ck0001534133-20251112_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="ck0001534133-20251112.xsd" xlink:type="simple"/>
    <context id="C_dad156a8-ea9f-4dad-b927-4953a81dc893">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
        </entity>
        <period>
            <startDate>2025-11-12</startDate>
            <endDate>2025-11-12</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="C_dad156a8-ea9f-4dad-b927-4953a81dc893"
      id="F_0fe438d5-d815-4235-bbcc-2899cc553d5d">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="C_dad156a8-ea9f-4dad-b927-4953a81dc893"
      id="F_de30911b-3b26-4825-88c5-e5c5cee43d2e">0001534133</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="C_dad156a8-ea9f-4dad-b927-4953a81dc893"
      id="F_6f290679-a266-4766-aa18-c401336efd6a">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="C_dad156a8-ea9f-4dad-b927-4953a81dc893"
      id="F_78b312ea-94d5-4c44-95d7-01d0747d287e">2025-11-12</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="C_dad156a8-ea9f-4dad-b927-4953a81dc893"
      id="F_e15b8fb4-9862-40df-8f50-6dce7229dea3">CalciMedica, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_dad156a8-ea9f-4dad-b927-4953a81dc893"
      id="F_6b234716-d73d-4c5c-a967-0135f750f42c">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="C_dad156a8-ea9f-4dad-b927-4953a81dc893"
      id="F_b6ceabb5-a6b0-4e7d-9a75-c4b182227ee0">001-39538</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="C_dad156a8-ea9f-4dad-b927-4953a81dc893"
      id="F_7776bd48-298a-4c7a-8308-565181636d93">45-2120079</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="C_dad156a8-ea9f-4dad-b927-4953a81dc893"
      id="F_4e71f8f1-c38d-48ba-8c50-ecda8cc176fc">505 Coast Boulevard South</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="C_dad156a8-ea9f-4dad-b927-4953a81dc893"
      id="F_38d1ec10-2d3c-4294-af75-18a8679008d7">Suite 307</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="C_dad156a8-ea9f-4dad-b927-4953a81dc893"
      id="F_98971ee8-4798-4c20-abbe-9beaac4a8740">La Jolla</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="C_dad156a8-ea9f-4dad-b927-4953a81dc893"
      id="F_dd217415-a9dc-46af-9610-a3841058a8a5">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="C_dad156a8-ea9f-4dad-b927-4953a81dc893"
      id="F_e518162e-56b1-435c-8292-95f5b5c23eb3">92037</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="C_dad156a8-ea9f-4dad-b927-4953a81dc893"
      id="F_434da006-8b79-4439-9a86-287e50d02af8">(858)</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_dad156a8-ea9f-4dad-b927-4953a81dc893"
      id="F_e9abc89c-93d1-4f41-8dd4-bb3179116e8d">952-5500</dei:LocalPhoneNumber>
    <dei:EntityInformationFormerLegalOrRegisteredName
      contextRef="C_dad156a8-ea9f-4dad-b927-4953a81dc893"
      id="F_b673a781-200e-4e3a-b8c2-1069cb8d2bae">Not Applicable</dei:EntityInformationFormerLegalOrRegisteredName>
    <dei:WrittenCommunications
      contextRef="C_dad156a8-ea9f-4dad-b927-4953a81dc893"
      id="F_894568ec-1375-4be7-96a9-6f9584010090">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="C_dad156a8-ea9f-4dad-b927-4953a81dc893"
      id="F_8f2a4934-cf62-47ef-b2bb-07701f3eeccf">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="C_dad156a8-ea9f-4dad-b927-4953a81dc893"
      id="F_412d8a88-34f2-4e2b-b945-7b9bad9644fa">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="C_dad156a8-ea9f-4dad-b927-4953a81dc893"
      id="F_88c10cef-b8a0-495b-bdb2-1dc2b7af5118">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="C_dad156a8-ea9f-4dad-b927-4953a81dc893"
      id="F_b06a85f0-bd12-41cd-90af-b15f9296ddad">Common Stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_dad156a8-ea9f-4dad-b927-4953a81dc893"
      id="F_56bd88d1-e8d5-4e68-9ca3-06d914723d71">CALC</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_dad156a8-ea9f-4dad-b927-4953a81dc893"
      id="F_a5aed3c8-74e0-4069-aae8-e0e5ffa35fea">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_dad156a8-ea9f-4dad-b927-4953a81dc893"
      id="F_2a0162da-4bb7-40df-9b6f-e6eb6630319d">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="C_dad156a8-ea9f-4dad-b927-4953a81dc893"
      id="F_4a2eaf91-70ec-477b-aebc-ce1bb4a88417">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
